John W. Higuchi has bought LPCN on 5 days since Mar 2020
Director at Lipocine Inc.
SEC CIK 0001579891 · Filings on SEC.gov ↗
John W. Higuchi's record
3 months after each buy, from the first price a copier could get.
2 buys have 3 months of prices so far. A record shows here at 3.
Every filing
5 filings since Mar 2020, newest first
About John W. Higuchi
John W. Higuchi is a Director at Lipocine Inc. (NASDAQ: LPCN), a position he has held since 2002.( He previously served as Vice President of Business Development and Corporate Treasurer at Lipocine and co-founded Theratech Inc., a transdermal drug delivery company, where he acted as Chairman.(
Currently, Higuchi serves as CEO of Aciont and is a co-founder and board member of Spriaso, LLC, which develops respiratory and primary care products, including an FDA-approved combination drug for respiratory therapy.( On April 6, 2026, he purchased 123,000 shares of Lipocine stock at $2.05 per share, increasing his direct ownership to 163,797 shares.( Higuchi holds a BS in Chemistry from Hope College and an MBA and MS in Information Systems from The George Washington University.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.